$LLY Recent News Drug-maker earnings come in ahead of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2013 at 9:24 AM

$LLY Recent News

Drug-maker earnings come in ahead of views, but stocks aren't rewarded 10:45 a.m. Oct. 23, 2013 - Russ Britt
Stock futures retreat; Cat misses on earnings 7:42 a.m. Oct. 23, 2013 - William L. Watts
Eli Lilly net profit down 9.3%, revenue rises 6:03 a.m. Oct. 23, 2013 - MarketWatch.com
Eli Lilly 3Q adj. EPS FactSet estimate was $1.04 5:39 a.m. Oct. 23, 2013 - Sara Sjolin
Eli Lilly 3Q revenue up 6% to $5.77 billion 5:38 a.m. Oct. 23, 2013 - Sara Sjolin
Eli Lilly 3Q net income down 9% to $1.20 billion 5:37 a.m. Oct. 23, 2013 - Sara Sjolin
Eli Lilly 3Q adj. EPS up 41% to $1.11 5:35 a.m. Oct. 23, 2013 - Sara Sjolin
Boeing, AT&T, Caterpillar are stocks to watch 4:31 a.m. Oct. 23, 2013 - Sue Chang
The market in a minute: Playing with volatility 7:42 a.m. Oct. 21, 2013 - The Trading Deck
Eli Lilly downgraded to underperform by Jefferies 8:21 a.m. Oct. 11, 2013 - Ben Eisen
Tesla stuck in reverse, Herbalife loses momentum 3:35 p.m. Oct. 3, 2013 - Sue Chang
Lilly unveils $5 billion share-buyback program 7:02 a.m. Oct. 3, 2013 - MarketWatch.com
J.C. Penney snaps losing streak; Facebook tops $50 3:36 p.m. Sept. 26, 2013 - Sue Chang
3 dividend stocks for worried investors 5:00 a.m. Sept. 9, 2013 - Jeff Reeves
Renaissance Technologies' top dividend picks 3:25 p.m. Aug. 23, 2013 - Insider Monkey
Tuesday’s movers: Airline stocks, Apple 3:32 p.m. Aug. 13, 2013 - Maria LaMagna
U.S. stocks rise with help from Apple Inc. 3:21 p.m. Aug. 13, 2013 - Kate Gibson
Updates, advisories and surprises 5:01 p.m. July 24, 2013 - MarketWatch
Lilly shares up on higher earnings, lower expenses; Elan also rises 11:00 a.m. July 24, 2013 - Russ Britt
Apple, AT&T, Boeing are stocks to watch Wednesday 8:24 a.m. July 24, 2013 - Maria LaMagna

4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
Lower-than-Expected Loss at OncoGenex - Analyst Blog 3:20 p.m. Nov. 8, 2013 - Zacks.com
Eli Lilly Goes Down The Hill As Patents Expire 1:46 p.m. Nov. 8, 2013 - Seeking Alpha
3 Huge Healthcare Trends Can Fatten Your Portfolio 4:00 a.m. Nov. 8, 2013 - InvestorPlace.com
Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS 8:28 a.m. Nov. 7, 2013 - 247WallSt.com
China Drags on Western Profits 12:23 a.m. Nov. 6, 2013 - WSJ.com
Prolific Selling - Hussman's High-Impact Moves Mirror Insiders 9:51 a.m. Nov. 5, 2013 - GuruFocus.com
We Like What We're Seeing In Big Pharma 4:15 a.m. Nov. 5, 2013 - Seeking Alpha
Drug Makers Get a Shot in the Arm 7:26 p.m. Nov. 3, 2013 - WSJ.com
Merck - Surprised Weakness In JANUVIA Is Causing Renewed Worries For Investors 2:10 p.m. Oct. 29, 2013 - Seeking Alpha
Eli Lilly Bulls: How Will 2014 Treat You? 10:08 a.m. Oct. 29, 2013 - Seeking Alpha
'Fast Money' Recap: Apple to the Core 5:00 a.m. Oct. 29, 2013 - TheStreet.com
Merck Profit Falls on Lower Sales 1:32 p.m. Oct. 28, 2013 - WSJ.com
Eli Lilly: Cymbalta Patent Expiry Quantified 12:48 p.m. Oct. 28, 2013 - Seeking Alpha
Narrower-than-Expected Q3 Loss at ImmunoGen - Analyst Blog 10:30 a.m. Oct. 28, 2013 - Zacks.com
4 Biotech Stocks Making Headlines 10:25 a.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Our Retirement Income Portfolio And Its 3rd Quarter Review 4:22 p.m. Oct. 25, 2013 - Seeking Alpha
Apple’s Mavericks Breaks Records, JPMorgan’s Legal Concerns, and 3 More Hot Stocks 1:37 p.m. Oct. 25, 2013 - Wall St. Cheat Sheet
Amarantus' LymPro May Be More Crucial For Alzheimer's Treatment Than We Think 8:38 a.m. Oct. 25, 2013 - Seeking Alpha

Morning Research: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc., and Endo Health Solutions Inc. 11:27 a.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Through 2022, Growth in the Neuropathic Pain Drug Market Will be Constrained by the Genericization of Sales-Leading Agents from Eli Lilly/Shionogi, Endo/Grunenthal and Pfizer 9:00 a.m. Nov. 4, 2013 - PR Newswire
Medtronic, Lilly Diabetes Join Together as First Ever National Presenting Sponsors of the JDRF Walk To Cure Diabetes 9:00 a.m. Nov. 1, 2013 - PR Newswire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
In Russia, the Use of Premium-Priced Novel Agents Will Expand the Acute Coronary Syndrome Market Through 2017 10:00 a.m. Oct. 29, 2013 - PR Newswire
Lessons From Hurricane Sandy: American College of Endocrinology (ACE) Urges Those With Diabetes to Plan Ahead 9:50 a.m. Oct. 29, 2013 - BusinessWire
The Alzheimer's Disease Drug Market Will Triple by 2022, Driven Largely by the Projected Launch of Eli Lilly's Solanezumab 9:00 a.m. Oct. 29, 2013 - PR Newswire
FDA Approves Addition to CIALIS® (tadalafil) Product Label 8:00 a.m. Oct. 25, 2013 - PR Newswire
Lilly announces Tapiero retiring; Zulueta promoted to senior vice president and president of Emerging Markets 5:00 p.m. Oct. 24, 2013 - PR Newswire
Critical Alerts For LinkedIn, MasterCard, News Corp, Eli Lilly, and ASML Holdings Released By InvestorsObserver 9:31 a.m. Oct. 24, 2013 - PR Newswire
Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals 8:00 a.m. Oct. 24, 2013 - PR Newswire
FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer 6:31 a.m. Oct. 23, 2013 - PR Newswire
Lilly Reports Third-Quarter 2013 Results 6:30 a.m. Oct. 23, 2013 - PR Newswire
Jackson Tai Elected to Lilly Board of Directors 10:21 a.m. Oct. 22, 2013 - PR Newswire
Jackson Tai Elected to Lilly Board of Directors 8:00 a.m. Oct. 22, 2013 - PR Newswire
Lilly Declares Fourth-Quarter 2013 Dividend 4:15 p.m. Oct. 21, 2013 - PR Newswire
ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Versatility of Novel Gene Expression and Control Technology 12:30 p.m. Oct. 21, 2013 - GlobeNewswire
The Carlyle Group and AlpInvest Assume Management of Two Indiana Life Sciences Funds of Funds Totaling $130 Million 7:00 a.m. Oct. 17, 2013 - BusinessWire
Awareness Programs, Restructuring Efforts, Conference Calls, Marketing Authorization Withdrawal and Clinical Trial Commencement - Research Report on Lilly, Teva, Elan, Zoetis, and Boston Scientific 8:00 a.m. Oct. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ViewScan Unveils New AI Solution and Enhanced Site

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

iFranchise Holds Top Spot in Consulting for 8 Years

iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....

Beemo, Choreo Forge AI Partnership for Wealth Management

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Saudi Arabia Unveils CEER's Flagship Electric Vehicles

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

GRAI's Innovative Play with Hangout FM in Streaming

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Holland America Overhauls Half Moon Cay Offerings

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Partners International Launches CareerPath for Youth

A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...

Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

FBI Vet Marcus Thomas Joins Re-fined Nonprofit Board

Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...